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Summary. To ensure the microbiological quality, consumer safety and organoleptic properties of cosmetic products, 
manufacturers need to comply with defined standards using several preservatives and disinfectants. A drawback regarding the 
use of these preservatives is the possibility of generating cross-insusceptibility to other disinfectants or preservatives, as well as 
cross resistance to antibiotics. Therefore, the objective of this study was to understand the adaptive mechanisms of Enterobacter 
gergoviae, Pseudomonas putida and Burkholderia cepacia that are involved in recurrent contamination in cosmetic products 
containing preservatives. Diminished susceptibility to formaldehyde-donors was detected in isolates but not to other preserva-
tives commonly used in the cosmetics industry, although increasing resistance to different antibiotics (β-lactams, quinolones, 
rifampicin, and tetracycline) was demonstrated in these strains when compared with the wild-type strain. The outer membrane 
protein modifications and efflux mechanism activities responsible for the resistance trait were evaluated. The development of 
antibiotic-resistant microorganisms due to the selective pressure from preservatives included in cosmetic products could be a 
risk for the emergence and spread of bacterial resistance in the environment. Nevertheless, the large contribution of disinfection 
and preservation cannot be denied in cosmetic products. [Int Microbiol 2015; 18(1):51-59]
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Microbial contamination of cosmetic products is a matter of 
great importance to the industry and it is potentially a major 
cause of both product and economic losses. Water and nutri-
ents present in cosmetics make them susceptible to microbial 
growth. Most often, microorganisms are the cause of organo-
leptic alterations, such as offensive odors, and changes in vis-
cosity and color. Moreover, in a few cases, contaminating 
microorganisms or their activity may cause human health 
problems, such as skin irritation, allergic contact dermatitis 
and infection, especially in the eyes, mouth or wounds 
[10,25,33,35]. To ensure microbiological quality, consumer 
safety and the organoleptic properties of cosmetic products, 
manufacturers need to use disinfectants and preservatives. 
Therefore, cosmetics need preservatives that are able to re-
duce the microbial load to acceptable levels during the period 
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of validity [17]. Regulations in the EU and in other countries 
permit specified preservatives, define their maximum concen-
trations, and provide other controls specifically related to the 
type of cosmetic product. Preservatives are added to cosmet-
ics in order to inhibit the proliferation of spoiling microorgan-
isms. Microbial quality assurance in cosmetics aims to pre-
vent the transmission of diseases by using these products 
properly, and ensures their stability and effectiveness [28]. 
Antibiotics are generally considered to be selectively toxic 
agents suitable for administration to patients, whereas bio-
cides have been traditionally regarded as antiseptics, disinfec-
tants or preservatives. Additionally, antibiotics are considered 
to have a specific target site within a bacterial cell, whereas 
biocides have multiple target sites. Unlike antibiotics, which 
are selectively toxic, most biocides do not act against a de-
fined target cell [22,23,32,36]. For example, triclosan inhibits 
the synthesis of agents that bind to enoyl-acyl carrier protein 
reductase, causing inhibition of fatty acid biosynthesis and 
disruption of the membrane, thus precipitating the cytoplas-
mic compounds [13]. Formaldehyde-donors/releasers act 
against bacterial cells by releasing formaldehyde into the me-
dium, and their biocidal effect is due to the cross-linking of 
proteins in the cell envelope and elsewhere in the cell, as well 
as cross-linking of RNA and DNA [34].
Exposure of bacteria to biocides can select for mutants 
with decreased biocide susceptibility, and these mutants of-
ten display a decreased susceptibility to various antibiotics, 
indicating that biocides can act as drivers of antibiotic resis-
tance under laboratory conditions [7,37]. It has been sug-
gested that cross-resistance to antimicrobial compounds, 
following exposure and adaptation to a biocide, could occur 
in a limited number of situations, such as when a biocide 
and antibiotic compound use the same entry mechanisms, 
have the same cellular target, can develop the same resis-
tance mechanism and, finally, when biocide tolerance and 
antibiotic resistance are potentially carried by the same mo-
bile genetic element [7]. Resistance to antimicrobial com-
pounds can emerge following one or more target gene mu-
tations, but it is difficult for bacteria to become resistant to 
the recommended concentrations used for many biocides, 
since mutations within a single gene will not usually confer 
resistance. In contrast, when tolerance to biocides arises, it 
is mediated by mechanisms that are less well characterized. 
Some of the modifications that can occur in a bacterial cell 
include upregulation of the efflux pump activity or struc-
tural alterations in the cell wall, which impact permeability. 
Efflux systems can export both antibiotics and many bio-
cides [36].
The extensive use of microbicides in a wide range of ap-
plications has been questioned with regard to their role in the 
development of bacterial resistance to antimicrobials. How-
ever, for natural isolates, there was no evidence that cross-re-
sistance between cosmetic preservatives and antibiotics could 
occur [30]. The aim of this study was to determine the mecha-
nisms of tolerance to formaldehyde-donors shown by bacte-
rial strains belonging to species of Enterobacter gergoviae, 
Pseudomonas putida and Burkholderia cepacia isolated from 
cosmetics products, and, because of human health concerns, 
to search for possible cross-resistance to antibiotics. 
Materials and methods
Bacterial strains. A total of 46 strains belonging to Enterobacter gergo­
viae, 22 to Pseudomonas putida and 44 to Burkholderia cepacia were ob-
tained from contaminated cosmetic formulations (shampoos, lotions, condi-
tioners) preserved with parabens and formaldehyde-donors. Strains were 
identified by the API system 20NE (Biomeriéux, Marcy l’Etoile, France). 
Reference strains from the American Type Culture Collection (ATCC) were 
also included in the study. Strains were cultured on trypticase soy agar (Dif-
co, Detroit, MI, USA) for E. gergoviae and P. putida, and on plate count agar 
(Difco) for B. cepacia.
Minimal inhibitory concentration (MIC) in solid medium. 
Susceptibility tests to 16 preservatives and 12 antibiotics were performed by 
serial dilutions in Mueller-Hinton agar (Difco). The inoculum consisted of 
104 colony forming units (CFU) per spot and the MIC was defined as the 
lowest concentration that prevented visible growth after incubation for 18 h 
at 35ºC. The following preservatives were studied: methylchloroisothiazoli-
none/methylisothiazolinone and polyaminopropyl biguanide (Thor, Speyer, 
Germany), DMDM hydantoin (McIntyre, Halifax, Canada), Quaternium-15 
(Evonik Degussa Ibérica, Barcelona, Spain), diazolidinyl urea, imidazolidi-
nyl urea and sodium hydroxymethylglycinate (International Specialty Prod-
ucts, West Milford, NJ, USA), methylparaben and propylparaben (Sharon 
Labs., Ashdod, Israel), methyldibromo glutaronitrile (Shülke, Nordersted, 
Germany), phenoxyethanol (Seppic, Paris, France), hexamidine isethionate 
(Laboratoires Sérobiologiques, Pulnoy, France), chlorphenesin (Arnaud, 
Paris, France), benzalkonium chloride (Comercial Química Massó, Barcelo-
na, Spain), bronopol (Basf, Ludwigshafen, Germany), and triclosan (Ciba 
Specialty Chemicals, Basel, Switzerland). Antibiotics were purchased from 
Sigma (Madrid, Spain). Working solutions were prepared daily in suitable 
sterile diluents. Antibiotics used were: cefotaxime, ceftazidime, ceftriaxone, 
kanamycin, streptomycin, tetracycline, erythromycin, ciprofloxacin, penicil-
lin, ampicillin, chloramphenicol, and novobiocin.
 
Outer membrane isolation and SDS-PAGE. Outer membrane 
proteins were obtained from cells cultivated in Luria Bertani broth (Difco), as 
described previously [20]. The inner membrane fraction was solubilized from 
disrupted cells by direct extraction with 2% sodium dodecyl sulfate and the 
outer membrane was separated by centrifugation (12,000 rpm, 60 min). The 
proteins obtained were analyzed by sodium dodecyl sulfate-12% polyacryl-
amide gel electrophoresis (SDS-PAGE). In order to enhance the resolution of 
protein bands, 4 M urea was added to the resolving gel.
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Microbial affinity to solvents (MATS) for selected strains. 
The MATS assay was carried out as previously described [11]. After over-
night culture, cells were harvested by centrifugation (7500 rpm, 10 min), 
washed twice with PBS (phosphate buffered saline) at pH 7.0, and resus-
pended in the same solution at a final optical density (OD
600
) of 0.8. Each 
bacterial suspension (2.4 ml) was mixed for 60 s at maximum intensity on a 
vortex-type agitator with 0.4 ml of chloroform, hexadecane, diethyl ether, or 
hexane (Panreac, Barcelona, Spain). The mixtures were allowed to stand for 
60 min to ensure complete separation of the two phases. A 1-ml sample was 
then carefully removed from the aqueous phase and its optical density was 
measured at 600 nm. The microbial affinity for each solvent was calculated 
using the formula:
% Affinity = (OD0 − ODf / OD0) × 100
where OD0 is the optical density of the bacterial suspension before mixing 
with the solvent and ODf the absorbance after mixing and phase separation. 
Each measurement was performed in duplicate and the experiment was re-
peated three times with independent bacterial cultures. Two solvent pairs 
were assayed: (i) chloroform (an acidic solvent) and hexadecane (an apolar 
solvent), and (ii) diethyl ether (a strong basic solvent) and hexane (an apolar 
solvent).
Ciprofloxacin accumulation and efflux assays. Ciprofloxacin 
accumulation and efflux assays were performed by a previously described 
fluorimetric method [3]. Briefly, isolates were incubated at 37°C until OD
600
 
= 0.5–0.7. Bacteria were harvested by centrifugation (7000 rpm) at room 
temperature, washed, and concentrated 10-fold in PBS pH 7.5. Ciprofloxacin 
was added to a final concentration of 10 µg/ ml. At timed intervals of 30 s, 1.5 
min, 3 min, 6 min, and 9 min, samples were centrifuged in a microfuge at 
10,000 rpm at 4°C for 15 s. Pellets were washed in 1 ml of chilled PBS at pH 
7.5, and suspended in 1 ml 0.1 M glycine–HCl buffer at pH 3.0, and finally 
incubated at room temperature overnight to allow bacterial lysis. The suspen-
sions were centrifuged at 20°C for 25 min in order to remove bacterial debris. 
The concentration of the antibiotic in the supernatants was determined fluoro-
metrically using an SLM Aminco 8100 spectrofluorometer. For the efflux 
assay, cells were incubated for 3 min with antibiotic before addition of the 
metabolic inhibitor CCCP (carbonyl cyanide m-chlorophenylhydrazone) at a 
final concentration of 100 µM, and samples were manipulated in the same 
way as for quinolone accumulation. The specific extinction and emission 
wavelengths used to identify ciprofloxacin were 279 and 447, respectively, 
and they were determined in 0.1 M glycine-HCl at pH 3.0.
Results 
Susceptibility of natural preservative-tolerant 
strains isolated from cosmetic products. The 
MICs of different preservatives commonly used in the cos-
metics industry were determined for Enterobacter gergoviae, 
Pseudomonas putida and Burkholderia cepacia strains. Re-
sults are shown in Table 1. Tolerance to preservatives was de-
fined as more than eight-fold the MIC compared to suscepti-
ble strains [24]. Regarding E. gergoviae, some strains showed 
tolerance to formaldehyde-donors, such as diazolidinyl urea, 
imidazolidinyl urea, Quaternium-15, sodium hydroxymethyl-
glycinate and DMDM hydantoin. No significant changes in 
susceptibility were found when other preservatives were test-
ed, such as parabens, isothiazolinone, bronopol, biguanide, 
methyldibromo glutaronitrile, chlorphenesin, phenoxyetha-
nol, benzalkonium chloride, triclosan or hexamidine. On the 
other hand, the strains with decreased susceptibility to form-
aldehyde-donors showed reduced susceptibility to β-lactam 
antibiotics (penicillin and cephalosporin), tetracycline and 
ciprofloxacin when compared to the preservative-susceptible 
Enterobacter strains. No increased resistance to novobiocin, 
macrolides (erythromycin), aminoglycosides (kanamycin, 
streptomycin) or chloramphenicol was found (Table 2). Simi-
lar results were observed for P. putida and B. cepacia (Table 1). 
Regarding antibiotics, reduced susceptibility was found in 
nearly all the drugs tested (Table 2). 
Surface characterization and permeability. To 
exert an antibacterial action, antimicrobial (preservatives/an-
tibiotics) must penetrate the cell envelope or accumulate 
therein at a sufficiently high concentration. Adaptation of the 
microbial cell envelope may contribute to the mechanism re-
sponsible for resistance to antimicrobial agents. As bacterial 
species differ in their envelope structures and, hence, in their 
intrinsic resistance to antibiotics [4,6,19,39], we studied outer 
membrane proteins, physicochemical characteristics of the 
cell surface and permeability that may influence cell suscepti-
bility to preservatives/antibiotics in three selected tolerant 
strains (E. gergoviae EU36, P. putida EU34 and B. cepacia 
EU67). 
The initial reaction of a biocide with a microbial cell in-
volves initial binding to the cell surface, although target sites 
might be found within the cell. The first reaction of any anti-
bacterial agent involves interaction with the outer cell mem-
brane in the case of Gram-negative bacteria and subsequent 
passage of the agent to the target site. Outer membrane pro-
teins from Enterobacter contain three porins, named OmpF, 
OmpC and OmpD [19,20]. E. gergoviae EU36 did not express 
the OmpF porin. Therefore, it seems that formaldehyde-do-
nors must enter into the bacterial cell through this porin, since 
the cell became tolerant when OmpF was not expressed in the 
outer membrane (Fig. 1). It has been described that hydro-
philic molecules pass through the outer membrane by porins 
[19,26]. Accordingly, porin-deficient strains did not show ei-
ther tolerance to hydrophobic preservatives (parabens, chlor-
phenesin, triclosan), or resistance to hydrophobic and higher-
molecular weight antibiotics, such as erythromycin. Pseudo­
monas putida EU34 and B. cepacia EU67 were tolerant to 
preservatives and did not show any changes in porin composi-
tion with respect to the susceptible strains (Fig. 1). Therefore, 
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Pseudomonas and Burkholderia must have another mecha-
nism implicated in tolerance to formaldehyde-donor preserva-
tives, as well as for increasing antibiotic resistance (this pat-
tern of porins was also observed in all the preservative-toler-
ant strains in this study). 
The charge and cell surface hydrophobicity may influence 
the interaction with antimicrobial agents [2]. Cationic com-
pounds, such as chlorhexidine and benzalkonium chloride, 
are thought to interact with negative charges in the bacterial 
cell wall and outer membrane [12]. The Lewis acid/base and 
Table 1. Minimal inhitory concenctratio (MIC) for the three species tested for preservatives. Results are expressed in µg/ml
MIC 
Enterobacter gergoviae Pseudomonas putida Burkholderia cepacia
Preservative No. strainsa MIC90
b No. strains MIC90 No. strains MIC90
DMDM hydantoin S (26) 1500 S (4) 412.5 S (16) 1650
R (20) 6000 R (18) 3850 R (28) 16500
Quaternium-15 S (26) 600 S (4) 300 S (16) 300
R (20) 2500 R (18) 7500 R (28) 2500
Imidazolidinyl urea S (26) 1500 S (4) 5000 S (16) 300
R (20) >7500 R (18) 17500 R (28) 6000
Diazolidinyl urea S (26) 300 S (4) 300 S (16) 600
R (20) 5000 R (18) 2500 R (28) 12500
Sodium hydroxymethylglycinate S (26) 625 S (4) 625 S (16) 1250
R (20) 1250 R (18) 3500 R (28) 2500
Methylparaben S (46) 2500 S (22) 2500 S (44) 2500
R (0) – R (0) – R (0) –
Propylparaben S (46) 500 S (22) 500 S (44) 500
R (0) – R (0) – R (0) –
MCI/MIc S (46) 15 S (22) 10 S (44) 12.5
R (0) – R (0) – R (0) –
Methyldibromo glutaronitrile S (46) 120 S (22) 100 S (44) 120
R (0) – R (0) – R (0) –
Phenoxyethanol S (46) 5000 S (22) 5000 S (44) 2500
R (0) – R (0) – R (0) –
Hexamidine isethionate S (46) 12.5 S (22) 25 S (44) 300
R (0) – R (0) – R (0) –
Chlorphenesin S (46) 3000 S () 3000 S (44) 1500
R (0) – R (0) – R (0) –
Benzalkonium chloride S (46) 125 S (22) 250 S (44) 100
R (0) – R (0) – R (0) –
Bronopol S (46) 15 S (22) 30 S (44) 25
R (0) – R (0) – R (0) –
Polyaminopropyl biguanide S (46) 25 S (22) 2500 S (44) 180
R (0) – R (0) – R (0) –
Triclosan S (46) <2.5 S (22) 50 S (44) 5
R (0) – R (0) – R (0) –
aS: susceptible strains; R: resistant strains.
bMIC90: MIC at which 90% of the isolates are inhibited.
cMCI/MI: methylchloroisothiazolinone/methylisothiazolinone.
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hydrophobicity of cell envelopes can be assessed by micro-
bial affinity to solvents (MATS) [8]. Monopolar solvents (i.e., 
chloroform and diethyl ether) were selected for the estimation 
of the Lewis acid/base character, and apolar solvents (hexane 
and hexadecane) were used to estimate the hydrophobicity 
properties. B. cepacia EU67 showed the most affinity to chlo-
roform (Lewis acid character or electron acceptor). Affinity 
for chloroform implies an increased number of protonated 
groups, such as NH3 and/or OH groups, on the bacterial sur-
face [15]. Affinity to diethyl ether (Lewis base or electron do-
nor) was observed in E. gergoviae EU36. Pseudomonas puti­
da EU34 had a moderate affinity to both chloroform (Lewis 
acid) and diethyl ether (Lewis base). In general, all strains 
showed a hydrophilic character due to the low affinity for 
apolar solvents such as hexadecane and hexane. However, 
Burkholderia displayed slowly increasing hydrophobicity 
compared to Enterobacter and Pseudomonas (Table 3).
Figure 2 shows the results of experiments comparing ci-
pro floxacin accumulation with and without inhibition by 
CCCP. After 6 min of bacterial exposure to ciprofloxacin, a 
species-specific steady-state concentration was achieved, con-
firming previously published data [3]. Ciprofloxacin accumu-
lation in E. gergoviae EU36 was lower than in the susceptible 
type strain ATTCC 12833 because of deficiency of the OmpF 
porin. Denergized cells with CCCP had similar steady-state 
accumulation. A slower entry of ciprofloxacin and a similarly 
Table 2. MIC results of antibiotics for the three species tested. Results are expressed in µg/ml
MIC 
Enterobacter gergoviae Pseudomonas putida Burkholderia cepacia
Antibiotic Strainsa MIC90
b Strains MIC90 Strains MIC90
Cefotaxime  S 0.075  S 6  S 5
 R 0.30  R 15  R 20
Ceftazidime  S 0.0125  S 0.5  S 1
 R 0.5  R 2.75  R 3.5
Ceftriaxone  S 0.025  S 2.75  S 7.5
 R 0.15  R 12.5  R 17.5
Kanamycin  S 0.3  S 0.25  S 15
 R 0.6  R 0.75  R 75
Streptomycin  S 0.5  S 2  S 10
 R 0.5  R 6.5  R 100
Tetracycline  S 1.25  S 2  S 35
 R 4  R 8  R 35
Erythromycin  S 10  S 10  S 70
 R 10  R 100  R 125
Ciprofloxacin  S 0.0025  S 0.0125  S 0.125
 R 0.01  R 0.05  R 1
Penicillin  S 20  S 180  S 100
 R 50  R 250  R 550
Ampicillin  S 6  S 100  S 350
 R 12.5  R 100  R 850
Chloramphenicol  S 10  S 75  S 17.5
 R 25  R 125  R 125
Novobiocin  S 350  S 700  S 3.1
 R 350  R 700  R 6.2
aS/R: susceptible/resistant to formaldehyde donors (DMDM hydantoin, Quarternium-15, imidazolidinyl urea, diazolidinyl urea, sodium 
hydroxymethylglycinate), respectively. For E. gergoviae, n (S) = 26, n (R) = 20. 
For P. putida, n (S) = 4, n (R ) = 18 and for B. cepacia n (S) = 16, n (R) = 28.
bMIC90: MIC at which 90% of the isolates are inhibited.
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efficient efflux pump compared to the susceptible type strain 
may be sufficient to explain the resistance observed in E. ger­
goviae EU36. Pseudomonas putida EU34 accumulated slight-
ly less than E. gergoviae EU36, but denergizated cells that ac-
cumulated ciprofloxacin had similar values to denergized En­
terobacter cells. In this case, the low entry for Pseudomonas 
and effective efflux pumps could explain the relative resistance 
observed, since the susceptible Pseudomonas type strain had a 
similar behavior to its preservative-tolerant counterpart. Burk­
holderia strains accumulated less ciprofloxacin than Pseudo­
monas, especially B. cepacia EU67, but Burkholderia had a 
very effective efflux system that was higher than those ob-
served in Pseudomonas and Enterobacter. Burkholderia pre-
servative-tolerant strains had a dramatically low entry, but no 
porin suppression was observed. Probably, surface characteris-
tics, such as hydrophobicity and the Lewis acid character, may 
have influenced the uptake of ciprofloxacin. 
Discussion
Preservatives are added to cosmetic formulations in order to 
inhibit the growth of microorganisms. They are normally used 
at high concentrations, which are rapidly bactericidal, but, in 
some circumstances, sublethal concentrations can occur in the 
products and this exerts selective pressure on the bacteria 
leading to reduced susceptibility to these preservatives. 
It has been proposed that antibiotics/biocides can pene-
trate the envelopes of Gram-negative bacteria by three routes: 
(i) the hydrophilic pathway, through water-filled porin chan-
nels; (ii) the hydrophobic pathway, through the lipid bilayer; 
and (iii) self-promoted, which involves the displacement of 
divalent cations that bridge adjacent lipopolysaccharide (LPS) 
molecules, thereby disrupting the structure of the outer mem-
brane and exposing areas of the phospholipid bilayer [27]. 
Table 3. Lewis acid-base and hydrophobicity surface characteristics
Microbial affinity to solvents (MATS)
Strains Chloroform Hexadecane Diethyl ether Hexane
Enterobacter gergoviae (EU36) 33.80 ± 0.7 7.17 ± 0.36 50.54 ± 3.11 13.89 ± 0.77
Pseudomonas  putida (EU34) 68.77 ± 7.62 14.14 ± 5.6 66.38 ± 2.6 33.24 ± 3.86






ol Fig. 1. SDS-PAGE of outer membrane 
proteins from Enterobacter gergoviae 
(A), Pseudomonas putida (B), and Burk­
holderia cepacia (C).
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Permeability (reduced entry and/or an overexpressed efflux 
system) may be considered as a common and basic mecha-
nism of resistance, which is perhaps even more frequent than 
target modification or production of antibiotic-inactivating 
enzymes.
Multidrug efflux pumps, especially those belonging to the 
resistance-nodulation-division family, play a major role in es-
tablishing the “intrinsic or acquired” resistance of Gram-nega-
tive bacteria to a wide range of toxic compounds, including 
antibiotics [16,31]. Efflux through RND-family pumps (e.g. 
AcrAB, MexAB–OprM) is driven by the proton motive force, 
an electrochemical gradient in which the movement of hydro-
gen ions drives the transport of the substrate that can be inhib-
ited by CCCP. AcrAB-TolC multidrug resistance confers resis-
tance to a wide variety of lipophilic and amphiphilic com-
pounds, such as dyes, detergents, and antimicrobial agents 
(ethidium bromide, crystal violet, sodium dodecyl sulfate, bile 
acids, tetracycline, chloramphenicol, fluoroquinolones, β-lac-
tams, erythromycin) [31]. The presence of similar systems has 
been reported for Enterobacteriaceae, and a strain of Entero­
bacter cloacae overexpressing the AcrAB system exhibited a 
reduction of porin gene expression [29]. A similar mechanism 
was probably responsible for the natural E. gergoviae isolates 
that were tolerant to preservatives and had increasing resis-
tance to several antibiotics used in this study. In previous stud-
ies using a series of E. gergoviae derivatives isolated with in-
creasing methylisothiazolinone–chloromethylisothiazolinone 
(MIT-CMIT) and triclosan concentrations, antibiotic suscepti-
bility has not been altered and a different mechanism of toler-
ance has been described [30]. Note that, no alteration in porin 
expression was observed in Pseudomonas nor in Burkholde­
ria; overexpression of the efflux system probably belongs to 
the RND (resistance-nodulation-cell division) family of trans-
porters [38]. Most of the efflux systems characterized in pseu-
domonads export both antibiotics and biocides. Resistance to 
formaldehyde-donors both in pseudomonads and enterobacte-
ria has been described by the action of formaldehyde-dehydro-
genases [18,21]; however, no specific assays were carried out 
to determine this enzymatic activity, since a large difference in 
the MIC of formaldehyde would be expected.
To date, there have been several reports of cross-resistance 
between antibiotics and disinfectants used in the food indus-
try and hospital environment [5,7,9,39], but, as far as we 
know, there has been no evidence that this could be possible 
for preservatives in cosmetics, except for laboratory selected 








Fig. 2. Steady-state accumulation of ciprofloxacin (cip) after 6 min exposure. The height of each column 
represents the mean of the results of three independent experiments. The standard deviations are indicated by 
the bars. Eg, Enterobacter gergoviae; Pp, Pseudomonas putida; Bc, Burkholderia cepacia.
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tibiotics in natural preservative-tolerant isolates was more 
than eight-fold the MIC with respect to susceptible strains. In 
some cases, such as ciprofloxacin, this increasing resistance 
was insufficient to encourage clinical resistance because the 
serum concentration of ciprofloxacin was still high. However, 
surviving cells would have the potential to mutate spontane-
ously to higher, more clinically relevant levels of resistance to 
quinolones (such as ciprofloxacin) or to other antibiotics 
[1,14]. Antibacterial agents and antibiotics share the same re-
sistance problem: resistance will certainly increase as the 
drug persists, especially at low levels (e.g., residues) for long 
periods of time. However, this concern is irrelevant with sub-
stances that do not leave residues (alcohols, bleaches, perox-
ides), although it could be possible with preservatives. 
It is claimed that all formaldehyde-donors/releasers are 
microbicidal on account of the formaldehyde released. How-
ever, in some cases, the low quantity of released formalde-
hyde may not be sufficient to create a biocidal action. We have 
shown that mechanisms other than formaldehyde-dehydroge-
nase activity could be responsible for a moderate tolerance to 
these preservatives. Also, we showed that formaldehyde-do-
nors must penetrate into the cell through a hydrophilic path-
way (porins) like some antibiotics and they could be sub-
strates for efflux pumps. 
As in clinical or veterinary practice, the development of 
antibiotic resistant strains, due in this case to the selective 
pressure from preservatives included in consumer products, 
could be a risk for human health. Nevertheless, the great con-
tribution of disinfection, preservation and acceptance of hy-
gienic measures that have supported advances in public health 
over the last century cannot be denied. Indeed, if reductions in 
the number of infections requiring antibiotic treatment can be 
achieved through the use of biocidal products, then this is 
likely to decrease rather than increase the incidence of antibi-
otic resistance. However, in order to preserve the role of bio-
cides in hygiene, it is paramount to prevent the emergence of 
bacterial resistance and cross-resistance through their appro-
priate and prudent use.
Competing interests. None declared.
References
1.  Berlanga M, Viñas M (2000) Salicylate induction of phenotypic resis-
tance to quinolones in Serratia marcescens. 46:279-282
2.  Berlanga M, Ruiz N, Hernandez-Borrell J, Montero T, Viñas M (2000) 
Role of the outer membrane in the accumulation of quinolones by Ser­
ratia marcescens. Can J Microbiol 46:716-722
3.  Berlanga M, Montero MT, Hernández-Borrell J, Viñas M (2004) Influ-
ence of the cell wall on ciprofloxacin susceptibility in selected wild-type 
Gram-negative and Gram-positive bacteria. Int J Antimicrob Agents 
23:627-630
4.  Bruchmann S, Dötsch A, Nouri B, Chaberny IF, Häussler S (2013) Quan-
titative contributions of target alteration and decreased drug accumula-
tion to Pseudomonas aeruginosa fluoroquinolone resistance. Antimicrob 
Agents Chemother 57:1361-1368
5.  Capita R, Riesco-Peláez F, Alonso-Hernando A, Alonso-Calleja C 
(2014) Exposure of Escherichia coli ATTCC 12806 to sublethal con-
centrations of food-grade biocides influences its ability to form biofilm, 
resistance to antimicrobials, and ultrastructure. Appl Environ Micro-
biol 80:1268-1280
6.  Choi C-W, Park EC, Yun SH, Lee S-Y, Lee YG et al. (2014) Proteomic 
characterization of the outer membrane vesicle of Pseudomonas putida 
KT2440. J Proteome Res 13:4298-4309
7.  Condell O, Iversen C, Cooney S, Power KA, Walsh C, Burgess C, Fan-
ning S (2012) Efficacy of biocides used in the modern food industry to 
control Salmonella enterica, and links between biocide tolerance and 
resistance to clinically relevant antimicrobial compounds. Appl Environ 
Microbiol doi:10.1128/AEM.075334-11 
8.  Djeribi R, Boucherit Z, Bouchloukh W, Zouaoui W, Latrache H, Hamadi 
F, Menaa B (2013). A study of pH effects on the bacterial surface physi-
cochemical properties of Acinetobacter baumannii. Colloids Surface B 
102:540-545
9.  Furi L, Ciusa ML, Knight D, Di Lorenzo V, Tocci N et al. (2013) Eval-
uation of reduced susceptibility to quaternary ammonium compounds 
and bisbiguanides in clinical isolates and laboratory-generated mutants 
of Staphylococcus aureus. Antimicrob Agents Chemother 57:3488-
3497
10. Giacomel CB, Dartora G, Dienfethaeler HS, Haas SE (2013) Investiga-
tion on the use of expired make-up and microbiological contamination of 
mascaras. Int J Cosmetic Sci doi:10.1111/ics12053
11. Giaouris E, Chapot-Chartier M-P, Briandet R (2009) Surface physico-
chemical analysis of natural Lactococcus lactis strains reveals the exis-
tence of hydrophobic and low charged strains with altered adhesive prop-
erties. J Food Microbiol 131:2-9
12. Gilber P, Moore LE (2005) Cationic antiseptics: diversity of action under 
a common epithet. J Appl Microbiol 99:703-715
13. Gomez-Escalada M, Russell AD, Maillard J-Y, Ochs D (2005) Triclos-
an–bacteria interactions: single or multiple target sites? Lett Appl Micro-
biol 41:476-481
14. González-Zorn B, Escudero JA (2012) Ecology of antimicrobial re-
sistance: humans, animals, food and environment. Int Microbiol 
15:101-109
15. Hamadi F, Latrache H, Zahir H, El Abed S, Ellouali M, Saad IK (2012) 
The relation between the surface chemical composition of Escherichia 
coli and their electron donor/electron acceptor (acid-base) properties. 
Res J Microbiol 7:32-40
16. Hinchliffe P, Symmons MF, Hughes C, Koronakis V (2013) Structure 
and operation of bacterial tripartite pumps. Annu Rev Microbiol 
67:221-242
17. Hiom SJ (2013) Preservation of medicines and cosmetics. In: Fraise 
AP, Maillard J-Y, Sattar SA (eds.) Principles and practice of disinfec-
tion, preservation and sterilization, John Wiley, Oxford, pp 388-407 
18. Ito K, Takahashi M, Yoshimoto T, Tsuru D (1994) Cloning and high-
level expression of the glutathione-independent formaldehyde dehydro-
genase gene from Pseudomonas putida. J Bacteriol 176:2483-2491
19. Jaskulski MR, Medeiros BC, Borges JV, Zalewsky R, Fonseca MEC et 
al. (2013) Assessment of extended-spectrum β-lactamase, KPC carbapen-
emase and porin resistance mechanisms in clinical samples of Klebsiella 
pneumonia and Enterobacter spp. Int Antimicrob Agents 42:76-79
Int. MIcrobIol. Vol. 18, 2015ANTIBIOTIC CROSS-RESISTANCE IN COSMETIC PRESERVATIVE 59
30. Périamé M, Pagès J-M, Davin-Regli (2014) Enterobacter gergoviae 
membrane modifications are involved in the adaptive response to preser-
vatives used in cosmetic industry. J Appl Microbiol 118:49-61
31. Piddock LJV (2006) Multidrug-resistance efflux pumps—not just for re-
sistance. Nat Rev Microbiol 4:629-636
32. Russell AD, McDonnell G (2000) Concentration: a major factor in study-
ing biocidal action. J Hosp Infect 44:1-3 
33. Saeb-Lima M, Solis-Arreola GV, Fernandez-Flores A (2015) Mycobac-
terial infection after cosmetic procedure with botulinum toxin A. J Clin 
Diagn Res doi:10.7860/JCDR/2015/11741.5756
34. Sheldon ATJr (2005) Antiseptic “resistance”: real or perceived threat? 
Clin Infect Dis 40:1650-1656
35. Warburton KL, Wilkinson M (2015) Contact allergy to methylisothiazo-
linone: Has there been any change? Experience of a UK centre. Contact 
Derm doi:10.1111/cod.12403
36. Webber MA, Whitehead RN, Mount M, Loman NJ, Pallen MJ, Piddock 
LJV (2015) Parallel evolutionary pathways to antibiotic resistance se-
lected by biocide exposure. J Antimicrob Chemother. doi:10.1093/jac/
dkv109
37. Whitehead RN, Overton TW, Kemp CL, Webber MA (2011) Exposure of 
Salmonella enterica serovar Typhimurium to high level biocide chal-
lenge can select multidrug resistant mutants in a single step. PLoS One 
6:e22833
38. Zhang L, Li XZ, Poole K (2001) Fluoroquinolone susceptibilities of ef-
flux-mediated multidrug-resistant Pseudomonas aeruginosa, Stenotro­
phomonas maltophilia and Burkholderia cepacia. J Antimicrob Che-
mother 48:549-552
39. Zhou G, Shi Q-S, Ouyang Y-S, Chen Y-B (2014) Involvement of outer 
membrane proteins and peroxide-sensor genes in Burkholderia cepacia 
resistance to isothiazolone. World J Microbiol Biotechnol 30:1251-1260
20. Kaneko M, Yamaguchi A, Sawai T (1984) Purification and characteriza-
tion of two kinds of porins from the Enterobacter cloacae outer mem-
brane. J Bacteriol 158:1179-1181
21. Kaulfers PM, Marquardt A (1991) Demonstration of formaldehyde dehy-
drogenase activity in formaldehyde-resistant Enterobacteriaceae. FEMS 
Microbiol Lett 79:335-338
22. Kohanski MA, Dwyer DJ, Collins JJ (2010) How antibiotics kill bacte-
ria: from targets to networks. Nat Rev Microbiol doi:10.1038/nrmi-
cro2333
23. Maillard JY (2002) Bacterial target sites for biocide action. J Appl Mi-
crobiol 92:16S-27S
24. McDonell G, Russell AD (1999) Antiseptics and disinfectants: activity, 
action, and resistance. Clin Microbiol Rev 12:147-179 
25. Molina-Cabrillana J, Bolaños-Rivero M, �lvarez-León EE, Martín Sán-
chez AM, Sánchez-Palacios M, �lvarez D, Sáez-Nieto JA (2006) Intrin-
sically contaminated alcohol-free mouthwash implicated in a nosocomial 
outbreak of Burkholderia cepacia colonization and infection. Infect Con-
trol Hosp Epidemiol 27:1281-1282
26. Nikaido H (2003) Molecular basis of bacterial outer membrane permea-
bility revisited. Microbiol Mol Biol Rev 67:593-656
27. Ortega Morente E, Fernández-Fuentes MA, Grande Burgos MJ, Abriouel 
H, Pérez Pulido R, Gálvez A (2013) Biocide tolerance in bacteria. Int J 
Food Microbiol doi:10.1016/j.ijfoodmicro.2012.12.028
28. Orús P, Leranoz S (2005) Current trends in cosmetic microbiology. Int 
Microbiol 8:77-79
29. Pérez A, Canle D, Latasa C, Poza M, Beceiro A, et al., (2007) Cloning, 
nucleotide sequencing, and analysis of the AcrAB-TolC eflux pump of 
Enterobacter cloacae and determination of its involvement in antibi-
otic resistance in a clinical isolate. Antimicrob Agents Chemother 
51:3247-3253
Int. MIcrobIol. Vol. 18, 2015 ORÚS ET AL.60
